Regional analgesia catheter infections and the effectiveness of antibiotic prophylaxis in immunosuppressed patients: A retrospective registry analysis

Regional analgesia catheter infections and the effectiveness of antibiotic prophylaxis in immunosuppressed patients: A retrospective registry analysis - RACIIP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031272

Enrollment

100000

Registered

2023-02-09

Start date

2023-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related infections in regional analgesia

Interventions

Group 1: Patients with presumably normal immune function Group 2: Immunosuppressed patients Group 3: Patients with presumably normal immune function and perioperative antibiotic prophylaxis Group 4: P

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All cases documented in the German Network for Safety in Regional Anesthesia and Acute Pain Therapy registry with a regional analgesic catheter placement (01.01.2007 until the day of data readout)

Exclusion criteria

Exclusion criteria: Implausible data entries

Design outcomes

Primary

Measure	Time frame
Time to infection	—

Secondary

Measure	Time frame
Degree of infection No infection: no signs of infection Mild infection: presence of 2 symptoms out of redness, swelling, and pain. Moderate infection: mild infection plus 2 criteria: increased C-reactive protein, leukocytosis, fever, or pus at the punctured site. Severe infection: necessity of surgical intervention such as incisions or revisions.	—

Countries

Germany

Contacts

Public ContactLukas Martin Müller-Wirtz

Universitätsklinikum des Saarlandes

lukas.mueller-wirtz@uks.eu+49 (0) 6841 16 22485

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026